Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainKinesin-like_KIF1-typ

KIF13B KIF1A

1.03e-054252IPR022140
DomainKIF1B

KIF13B KIF1A

1.03e-054252PF12423
DomainKinesin_assoc

KIF13B KIF1A

2.57e-056252PF16183
DomainDUF3694

KIF13B KIF1A

2.57e-056252PF12473
DomainKinesin-like

KIF13B KIF1A

2.57e-056252IPR022164
DomainKinesin_assoc

KIF13B KIF1A

2.57e-056252IPR032405
DomainFHA

KIF13B KIF1A

6.36e-0428252SM00240
DomainFHA_DOMAIN

KIF13B KIF1A

7.81e-0431252PS50006
DomainFHA

KIF13B KIF1A

7.81e-0431252PF00498
DomainFHA_dom

KIF13B KIF1A

1.05e-0336252IPR000253
Domain-

KIF13B KIF1A

1.05e-03362522.60.200.20
DomainKinesin_motor_CS

KIF13B KIF1A

1.37e-0341252IPR019821
DomainKinesin-like_fam

KIF13B KIF1A

1.50e-0343252IPR027640
DomainKINESIN_MOTOR_1

KIF13B KIF1A

1.57e-0344252PS00411
Domain-

KIF13B KIF1A

1.57e-03442523.40.850.10
DomainKinesin_motor_dom

KIF13B KIF1A

1.57e-0344252IPR001752
DomainKinesin

KIF13B KIF1A

1.57e-0344252PF00225
DomainKISc

KIF13B KIF1A

1.57e-0344252SM00129
DomainKINESIN_MOTOR_2

KIF13B KIF1A

1.57e-0344252PS50067
DomainSMAD_FHA_domain

KIF13B KIF1A

2.19e-0352252IPR008984
DomainUSP_CS

USP7 USP4

3.50e-0366252IPR018200
DomainUSP_1

USP7 USP4

3.93e-0370252PS00972
DomainUCH

USP7 USP4

4.04e-0371252PF00443
DomainUSP_2

USP7 USP4

4.04e-0371252PS00973
DomainUSP_3

USP7 USP4

4.15e-0372252PS50235
DomainUSP_dom

USP7 USP4

4.15e-0372252IPR028889
DomainPeptidase_C19_UCH

USP7 USP4

4.15e-0372252IPR001394
Pubmed

The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.

USP7 USP4

4.95e-06525231748695
Pubmed

Deubiquitylation and stabilization of PTEN by USP13.

USP7 USP4

1.04e-05725224270891
Pubmed

Polycomb protein SCML2 associates with USP7 and counteracts histone H2A ubiquitination in the XY chromatin during male meiosis.

USP7 SYCP2

1.39e-05825225634095
Pubmed

The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types.

USP7 USP4

1.78e-05925222195557
Pubmed

Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.

CDK9 USP7

2.72e-051125228655758
Pubmed

Deubiquitinating enzymes: a new class of biological regulators.

USP7 USP4

5.18e-05152529827704
Pubmed

Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.

CDK9 USP7

1.03e-042125230179224
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

CDK9 USP7 ENDOG ALOX5 FURIN ITPR3

1.07e-04110525635748872
Pubmed

Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling.

USP7 USP4

1.14e-042225226811477
Pubmed

Defining the membrane proteome of NK cells.

CDK9 CD302 NUP107 SLC29A1 FURIN ITPR3

1.45e-04116825619946888
Pubmed

Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome.

KIF13B KIF1A

1.47e-04252529275178
Pubmed

Roles and functions of HIV-1 Tat protein in the CNS: an overview.

CDK9 FURIN

1.72e-042725224359561
Pubmed

Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

USP7 USP4

1.85e-042825222118674
Pubmed

OTUD6A Is an Aurora Kinase A-Specific Deubiquitinase.

USP7 USP4

2.43e-043225233669244
Pubmed

DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.

CDK9 RBM5

2.74e-043425232152128
Pubmed

A microarray of ubiquitylated proteins for profiling deubiquitylase activity reveals the critical roles of both chain and substrate.

USP7 USP4

3.08e-043625222626734
Pubmed

All kinesin superfamily protein, KIF, genes in mouse and human.

KIF13B KIF1A

3.25e-043725211416179
Pubmed

STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency.

USP7 NUP107 ITPR3

3.48e-0419225332176739
Pubmed

MITOL regulates phosphatidic acid-binding activity of RMDN3/PTPIP51.

USP7 ITPR3

4.00e-044125234964862
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

KIF1A SLC29A1 FURIN ITPR3

4.33e-0450425434432599
Pubmed

Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome.

NUP107 ITPR3

4.40e-044325234672947
Pubmed

Establishment and Dysfunction of the Blood-Brain Barrier.

ABCC2 SLC29A1

6.43e-045225226590417
Cytoband9q34.1

CDK9 ENDOG

4.84e-05192529q34.1
Cytoband3p21.3

RBM5 USP4

4.78e-04592523p21.3
CytobandEnsembl 112 genes in cytogenetic band chr10q11

VSTM4 ALOX5

4.70e-03188252chr10q11
GeneFamilyKinesins|Pleckstrin homology domain containing

KIF13B KIF1A

1.17e-0346202622
GeneFamilyUbiquitin specific peptidases

USP7 USP4

1.73e-0356202366
ToppCelldroplet-Liver-Npc-18m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF1A ENDOG DCT

8.07e-0515125386efabf27c264c856dca1cffacb16cef52e9863c
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B KIF1A ITPR3

1.45e-041842537aa245b73e10fd73d292e822de6b72920aa12355
ToppCelldroplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CD302 PDK4 ALOX5

1.45e-0418425315ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCelldroplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CD302 PDK4 ALOX5

1.45e-04184253bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCellBAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CD302 PDK4 ALOX5

1.47e-041852539aea5ed8f9cee5ee933891203aac7adb85d68201
ToppCellBAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD302 PDK4 ALOX5

1.47e-04185253ae966929fb5bbb08ffcbac76cb21941638727f55
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CD302 PDK4 ALOX5

1.47e-041852533beebaa92275086b1fae5f8c0c3d54016c5ba2aa
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD302 PDK4 ALOX5

1.47e-04185253ceff11cfa679147ccfd0a0f8079e697a6bea34d9
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CD302 PDK4 ALOX5

1.47e-0418525342939b294ea3e871274d8b73124c850dc1904fd2
ToppCellSevere_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）

CD302 PDK4 ALOX5

1.47e-04185253f7ef0d7740b4cfedc38846e802898c402dc411fd
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD302 ALOX5 FURIN

1.47e-04185253afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CD302 PDK4 ALOX5

1.47e-041852537a3612520ae4f0cd61480eadba31eecce001419d
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PDK4 SLC29A1 FURIN

1.59e-0419025363018acb7ad80415e861643162abdc2e55968ee4
ToppCell(1)_Control_(PBS)|World / Stress and Cell class

VSTM4 CD302 SLC29A1

1.62e-04191253b346e13259cb2d506b923ad44b894c21a3eee4c3
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B KIF1A ITPR3

1.64e-041922533fc7a661ef39286abfd82ed8ab580011f01cb8fd
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD302 PDK4 SLC29A1

1.72e-041952539a9e074f7ac04656dccbed2f0df11377e33d3c05
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B KIF1A ITPR3

1.72e-041952539fea1ddb68da83ca43dd8006c9e51295b1817f0e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD302 PDK4 ALOX5

1.72e-04195253704a12ac0c71af4a9cfb2473490b9a7c05dc42d7
ToppCelldroplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VSTM4 CD302 SLC29A1

1.72e-04195253d663d54a4bcc94e2c9b50ed931e2b2db4ca41373
ToppCell10x5'-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue

PDK4 SLC29A1 ALOX5

1.72e-0419525388d65c7c3a28922c125bd9f7c403a55d7d4d83a9
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF13B KIF1A ITPR3

1.74e-041962539afd0a7135028a446f06bb68f334e79b8f171b45
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD302 PDK4 ALOX5

1.74e-0419625389ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9
ToppCell3'_v3-Lung|World / Manually curated celltypes from each tissue

CD302 PDK4 ALOX5

1.74e-04196253a04f8384b734ce67ec402e64bd891a6274f04744
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD302 PDK4 ALOX5

1.74e-0419625309574bfeb1d3da53b5471cfb0602946d328b3b5c
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

RBM5 SYCP2 ENDOG

1.77e-041972530fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD302 PDK4 ALOX5

1.77e-04197253321ccd20b0bb03c99a00452ac3c637ee3aa73ecf
ToppCellsevere_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2)

CD302 PDK4 SLC29A1

1.80e-04198253790ee20abc9666b8095675b0d445c0914ee70ea3
ToppCell10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PDK4 SLC29A1 ALOX5

1.80e-04198253e1a0c809302a3b304775bd708201ad412a98d711
ToppCell5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VSTM4 CD302 PDK4

1.80e-041982537582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PDK4 SLC29A1 ALOX5

1.80e-041982539aced8bdb56ee52866a0a9766a84336961bc4443
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD302 SLC29A1 ALOX5

1.82e-04199253de9c1c801eb34faf01760df07d5ff6bbd561e152
ToppCellHealthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2)

CD302 PDK4 ALOX5

1.82e-0419925345e9099a13becb1e235435ceaaffb92b82ce34ee
ToppCell3'-Parenchyma_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CD302 PDK4 ALOX5

1.82e-04199253bc064ccfec8c1e96079b89b05aeebddf48bc87f3
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD302 SLC29A1 ALOX5

1.82e-0419925345e2f44a0ed39cb9ba061a03874c1fe746856c2d
ToppCellBronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

CD302 PDK4 ALOX5

1.82e-04199253fb63885273d906a85fef178d859d20a311eb8a72
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

USP7 ALOX5 FURIN

1.85e-04200253cc8368665bc6bb7c4f39632ccff07ceaa98a7b65
ToppCellBronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CD302 PDK4 ALOX5

1.85e-042002533981873eceb69412ec02a35a734965472853c3fc
ToppCellBronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CD302 PDK4 ALOX5

1.85e-04200253c439d4c62732ad660a60bc6577a4a6ca0f32a5b7
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

USP7 ALOX5 FURIN

1.85e-042002530d76b006d8e8b32174e65e400acd0674354b962c
DrugMefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A

CD302 PTPN21 DCT PDK4 ITPR3

1.80e-061992455534_UP
Drugbendrofluazide

VEZF1 DCT FURIN

9.17e-0639243CID000002315
DrugPiroxicam [36322-90-4]; Up 200; 12uM; PC3; HT_HG-U133A

CDK9 RBM5 SYCP2 PTPN21

4.85e-051952442089_UP
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A

CD302 SYCP2 PTPN21 KIF1A

4.85e-051952441668_DN
DrugHexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 ABCC2 KIF1A FURIN

4.95e-051962444965_UP
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A

RBM5 KIF13B PTPN21 ITPR3

5.04e-051972445238_DN
DrugButylparaben [94-26-8]; Up 200; 20.6uM; HL60; HT_HG-U133A

DCT PDK4 ALOX5 FURIN

5.04e-051972443069_UP
DrugFlunixin meglumine [42461-84-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A

KIF13B SYCP2 PTPN21 PDK4

5.04e-051972443411_UP
Drugarachidonyl trifluoromethyl ketone; Down 200; 10uM; MCF7; HG-U133A

RBM5 USP4 FURIN ITPR3

5.14e-05198244594_DN
DrugNiflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A

RBM5 KIF1A SLC29A1 FURIN

5.14e-051982445490_DN
DrugFlucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A

RBM5 PTPN21 KIF1A PDK4

5.14e-051982445289_UP
DrugBumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A

RBM5 PTPN21 ABCC2 PDK4

5.25e-051992445542_UP
DrugCloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A

SYCP2 PTPN21 PDK4 ITPR3

5.35e-052002447483_UP
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A

CD302 SYCP2 PTPN21 KIF1A

5.35e-052002441666_DN
DrugCacodylic Acid

CDK9 USP7 ABCC2 PDK4

1.50e-04261244ctd:D002101
DrugHeptachlor

ABCC2 PDK4 SLC29A1

2.12e-04111243ctd:D006533
Drugmercury

ABCC2 NUP107 DCT FURIN ITPR3

2.19e-04542245CID000023931
DrugN-acetylcysteine

USP7 ABCC2 ENDOG ALOX5 ITPR3

2.27e-04546245CID000000581
DrugBN 50730

ALOX5 FURIN

2.43e-0422242CID003033963
DrugAC1L1HQM

DCT ALOX5

2.43e-0422242CID000004248
DrugAC1O43P4

ABCC2 ITPR3

3.15e-0425242CID006323279
DrugT0702

ALOX5 ITPR3

3.15e-0425242CID000005908
Drughexylamine

CDK9 SLC29A1

3.15e-0425242CID000008102
DrugNSC243805

ALOX5 FURIN

3.68e-0427242CID000316274
Drugethacrynic acid

KIF13B ABCC2 KIF1A

4.02e-04138243CID000003278
Drugindirubin-3'-monoxime

CDK9 SLC29A1

4.25e-0429242CID005326739
DrugAC1MIZJD

ABCC2 FURIN

4.25e-0429242CID003082805
DrugLoratadine

ABCC2 ALOX5

4.55e-0430242ctd:D017336
Drugbenzothiazole

ABCC2 ALOX5

5.18e-0432242CID000007222
Drugmontelukast

ABCC2 ALOX5

6.20e-0435242ctd:C093875
DrugLeukotriene C4

ABCC2 ALOX5

6.20e-0435242ctd:D017997
Drug2-(aminomethyl)pyrrolidine

SLC29A1 ALOX5 ITPR3

6.30e-04161243CID000072032
Drugbaicalin

ABCC2 ALOX5

6.56e-0436242ctd:C038044
Drugtsuwabukinonol

ALOX5 FURIN

6.93e-0437242CID006440419
Drugcyclopropane

RBM5 SLC29A1

6.93e-0437242CID000006351
DrugLanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A

RBM5 PTPN21 ALOX5

7.89e-041742436048_UP
DrugTrimethylsilyl

VEZF1 ALOX5

8.11e-0440242CID000123362
DrugEthoxyquin

ABCC2 ALOX5

8.11e-0440242ctd:D005015
DrugBilirubin

RBM5 CD302 ABCC2

8.16e-04176243ctd:D001663
Drug5'-dFUrd

SLC29A1 FURIN

8.52e-0441242CID000003159
DrugAtorvastatin Calcium

ABCC2 PDK4 SLC29A1

9.57e-04186243ctd:D000069059
DrugQuercetine dihydrate [6151-25-3]; Up 200; 11.8uM; HL60; HT_HG-U133A

SYCP2 ABCC2 PDK4

1.00e-031892432499_UP
DrugNocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A

ABCC2 KIF1A FURIN

1.02e-031902437145_UP
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

KIF1A ENDOG SLC29A1

1.02e-031902436177_DN
Drugretinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA

CD302 SYCP2 PTPN21

1.03e-03191243991_DN
DrugBeta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A

USP7 KIF13B PTPN21

1.03e-031912433890_DN
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

ENDOG SLC29A1 ITPR3

1.03e-031912432685_DN
DrugNitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A

PTPN21 SLC29A1 ITPR3

1.03e-031912436721_DN
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

ENDOG SLC29A1 FURIN

1.05e-031922436166_DN
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A

USP7 KIF1A SLC29A1

1.06e-031932436938_UP
DrugKetotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A

RBM5 ABCC2 FURIN

1.06e-031932433200_DN
DrugCefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A

USP7 KIF1A FURIN

1.06e-031932434245_DN
DrugEthynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A

RBM5 KIF13B SYCP2

1.06e-031932435024_DN
Drugtroglitazone; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 PTPN21 SLC29A1

1.06e-031932431657_UP
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

PTPN21 SLC29A1 FURIN

1.06e-031932434338_DN
Diseasebrain ischemia (implicated_via_orthology)

SLC29A1 ALOX5

3.71e-0435242DOID:2316 (implicated_via_orthology)
DiseaseNon-alcoholic Fatty Liver Disease

ABCC2 PDK4

1.48e-0370242C0400966
DiseaseNonalcoholic Steatohepatitis

ABCC2 PDK4

1.48e-0370242C3241937
Diseasealanine measurement

PDK4 ALOX5

2.22e-0386242EFO_0009765
Diseasepancreatic cancer (is_marker_for)

ABCC2 ALOX5

3.05e-03101242DOID:1793 (is_marker_for)
Diseaseopioid use disorder

USP4 FURIN

3.05e-03101242EFO_0010702
Diseaseexecutive function measurement

USP4 ABCC2 FURIN

3.41e-03376243EFO_0009332
Diseasecannabis dependence

USP4 FURIN

5.37e-03135242EFO_0007191

Protein segments in the cluster

PeptideGeneStartEntry
DTDDASFKWFDNSNM

CD302

96

Q8IX05
AHETFNEWFKHMNSV

NUP107

756

P57740
FFDQSSFLHNEMEWQ

ITPR3

2171

Q14573
DMDFEDDQHFAKQDW

KIAA1107

1171

Q9UPP5
SAFKHYQMSSEADDW

PDK4

381

Q16654
MSAFVDNHHEWFRFS

HECW2

1296

Q9P2P5
AMQFSEASFTWEHDS

ABCC2

636

Q92887
EFYHLQDATSWMEAN

RBM5

146

P52756
HSFAVEWMQDFEAFQ

GPN1

196

Q9HCN4
WHDIANMSHNKSFFA

PTPN21

256

Q16825
SFASFDDQQKMWFTE

CEFIP

736

Q711Q0
SFAWHMSAFEDTDQR

C4orf45

136

Q96LM5
HDYSADGFNDWAFMT

FURIN

521

P09958
ISSMDHAFHANTWKF

C1orf112

171

Q9NSG2
SDDALNHDFFWSDPM

CDK9

306

P50750
TFYQFEAAWDSSMHN

KIF1A

1236

Q12756
FAYDHCFWSMDESVK

KIF13B

56

Q9NQT8
HMFQSSWNDFADFEK

ALOX5

196

P09917
ANHRWSQKAMDDTFY

ENDOG

146

Q14249
FMDEDLSFFSGWVQH

PRAMEF22

161

A3QJZ6
SFEFDMTHKQISQWF

NANOGNB

136

Q7Z5D8
EHDAWFIFFMAAFAF

SLC29A1

391

Q99808
FDSWDMYNVGEHNLF

USP4

51

Q13107
MEANWTAFLFQAHEA

VEZF1

1

Q14119
LSFEHDAWMSKQFQA

TRAPPC11

311

Q7Z392
AHQWFSMDFIAKAFK

SYCP2

236

Q9BX26
HSFTDAIFDEWMKRF

DCT

396

P40126
RWFFAHSFDSQEALM

VSTM4

61

Q8IW00
KSFGWETLDSFMQHD

USP7

281

Q93009